Preliminary findings from a phase I, open-label, dose-finding study of SNB-101 in patients with advanced solid tumors

被引：0
|
作者：
Sang, Y. B. [1 ]
Kim, Y. [1 ]
Lee, M. A. [2 ]
Rha, S. Y. [3 ]
Jung, M. [3 ]
Lee, C-K. [3 ]
Park, Y. H. [4 ]
Heo, D. [4 ]
Kim, A. [4 ]
Kim, J. [4 ]
Kim, J-H. [1 ]
机构：
[1] CHA Univ, Med Oncol, CHA Bundang Med Ctr, Seongnam, South Korea
[2] Catholic Univ Korea, Seoul St Marys Hosp, Med Oncol, Seoul, South Korea
[3] Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Med Oncol, Seoul, South Korea
[4] SN BioSci, Med Oncol, Seongnam, South Korea
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1863
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
677P
引用
收藏
页码：S474 / S474
页数：1
相关论文
共 50 条
  • [1] An open-label, dose-finding study of the combination of satraplatin and gemcitabine in patients with advanced solid tumors
    Di Paola, Eugenio Donato
    Alonso, Silvia
    Giuliani, Rosa
    Calabro, Fabio
    DAlessio, Antonietta
    Regine, Giovanni
    Cerbone, Linda
    Bianchi, Laura
    Mancuso, Andrea
    Sperka, Sabine
    Rozencweig, Marcel
    Sternberg, Cora N.
    FRONTIERS IN ONCOLOGY, 2012, 2
  • [2] Biweekly vinorelbine and gemcitabine:: a phase I dose-finding study in patients with advanced solid tumors
    Castellano, D
    Hitt, R
    Ciruelos, E
    Cortés-Funes, H
    Colomer, R
    ANNALS OF ONCOLOGY, 2003, 14 (05) : 783 - 787
  • [3] A phase I dose-finding study of pemetrexed combined with paclitaxel in patients with advanced solid tumors
    Bolling, C.
    Luebbing, C.
    Graefe, T.
    Mueler-Hagen, S.
    Leisner, B.
    Blatter, J.
    Hanauske, A.-R.
    EJC SUPPLEMENTS, 2005, 3 (02): : 421 - 421
  • [4] Adavosertib in Combination with Olaparib in Patients with Refractory Solid Tumors: An Open-Label, Dose-Finding, and Dose-Expansion Phase Ib Trial
    Hamilton, Erika P.
    Falchook, Gerald S.
    Wang, Judy S.
    Fu, Siqing
    Oza, Amit M.
    Imedio, Esteban Rodrigo
    Kumar, Sanjeev
    Ottesen, Lone
    Mugundu, Ganesh M.
    de Bruin, Elza C.
    O'Connor, Mark J.
    Jones, Suzanne F.
    Spigel, David R.
    Li, Bob T.
    TARGETED ONCOLOGY, 2024, 19 (06) : 879 - 892
  • [5] An open-label phase I dose-finding study of APR-246 in hematological malignancies
    Deneberg, S.
    Cherif, H.
    Lazarevic, V.
    Andersson, P-O
    von Euler, M.
    Juliusson, G.
    Lehmann, S.
    BLOOD CANCER JOURNAL, 2016, 6 : e447 - e447
  • [6] A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors
    Poveda, Andres
    Oaknin, Ana
    Romero, Ignacio
    Guerrero-Zotano, Angel
    Farinas-Madrid, Lorena
    Rodriguez-Freixinos, Victor
    Mallol, Pedro
    Lopez-Reig, Raquel
    Antonio Lopez-Guerrero, Jose
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [7] A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors
    Andres Poveda
    Ana Oaknin
    Ignacio Romero
    Angel Guerrero-Zotano
    Lorena Fariñas-Madrid
    Victor Rodriguez-Freixinos
    Pedro Mallol
    Raquel Lopez-Reig
    Jose Antonio Lopez-Guerrero
    Scientific Reports, 11
  • [8] Clofarabine administered weekly to adult patients with advanced solid tumors in a phase I dose-finding study
    Cunningham, CC
    Nemunaitis, J
    Senzer, N
    Vukelja, S
    Weiss, J
    Ferrier, A
    Vukovic, V
    Weitman, S
    Richards, D
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 223S - 223S
  • [9] An open-label phase I dose-finding study of APR-246 in hematological malignancies
    S Deneberg
    H Cherif
    V Lazarevic
    P-O Andersson
    M von Euler
    G Juliusson
    S Lehmann
    Blood Cancer Journal, 2016, 6 : e447 - e447
  • [10] Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors
    Fornier, M. N.
    Rathkopf, D.
    Shah, M.
    Patil, S.
    O'Reilly, E.
    Tse, A. N.
    Hudis, C.
    Lefkowitz, R.
    Kelsen, D. P.
    Schwartz, G. K.
    CLINICAL CANCER RESEARCH, 2007, 13 (19) : 5841 - 5846
12345